首页> 中文期刊> 《继续医学教育》 >医院感染铜绿假单胞菌肺炎细菌耐药性及预后探讨

医院感染铜绿假单胞菌肺炎细菌耐药性及预后探讨

             

摘要

Objective To explore the hospital infection with pseudomonas aeruginosa pneumonia in the prognosis of bacterial drug resistance situation and relevant factors, make a full guidance for clinical treatment. Methods Our hospital from June 2013 to June 2015, 135 cases of infection with pseudomonas aeruginosa pneumonia patients. For all patients with clinical data were retrospectively analyzed. Results According to the study of 135 cases of pseudomonas aeruginosa infection in patients with pneumonia. 45 cases of neurosurgery patients, 37 patients with respiratory medicine, 20 patients with nerve internal medicine, surgical ICU patients with 18 patients with 15 cases and other departments. For pseudomonas aeruginosa in view of the clinical application of common antibacterial drugs have resistance to pseudomonas analysis found that the percentages of the lowest percentages of drugs to cefoperazone/shu tan. Conclusion Hospital neurosurgery patients showed more easily pseudomonas aeruginosa pneumonia, its for showed the lower resistance to cefoperazone, for aztreonam showed higher resistance.%目的:探讨医院感染铜绿假单胞菌肺炎细菌的耐药情况以及相关的预后因素,为临床疾病治疗做出充分指导。方法选择我院2013年6月~2015年6月铜绿假单胞菌肺炎感染患者135例。对所有患者的临床资料实施回顾性分析。结果针对本次研究的135例铜绿假单胞菌肺炎感染患者。其中神经外科患者45例,呼吸内科患者37例,神经内科患者20例,外科ICU患者15例以及其他科室患者18例。对于铜绿假单胞菌针对临床应用普遍抗假单胞菌抗菌药物具有的耐药率进行分析发现,耐药率最低的药物为头孢哌酮/舒巴坦。结论医院神经外科患者较易表现出铜绿假单胞菌肺炎的情况,其针对头孢哌酮表现出较低的耐药率,针对氨曲南表现出较高的耐药率。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号